Journal Mobile Options
Table of Contents
Vol. 121, No. 1, 2000
Issue release date: January 2000

Characterization of T Cell Subpopulations Involved in the Pathogenesis of Asthma and Allergic Diseases

Yssel H. · Groux H.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Allergic asthma is a complex and heterogeneous disease which is characterized by intermittent reversible airway obstruction, chronic inflammation of the airways, bronchial hyperreactivity and an infiltration of lymphocytes and eosinophils into the airway submucosa. Animal models and clinical studies in humans have indicated an important role for T helper type 2 lymphocytes, producing IL-4, IL-5 and IL-13, in the pathogenesis of this disorder. However, although IL-4 and IL-13 have strong anti-inflammatory properties, the physiologic anti-inflammatory Th2 response does not seem to be operational in allergic asthma. Moreover, the induction of a Th1 response seems to aggravate, rather than ameliorate, its inflammatory character. This article will focus on the involvement of T lymphocyte subpopulations in the pathogenesis of allergic asthma and allergic diseases. In addition, a potential role of the subpopulation(s) of T regulatory cells in the induction and/or maintaince of the disease process will be discussed.

Copyright © 2000 S. Karger AG, Basel



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Global Initiative for Asthma: A global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. Bethesda, National Institutes of Health, National Heart, Lung and Blood Institute, 1995, publication No. 95-3659.
  2. Mosmann TR, Coffman RL: Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145–173.
  3. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996;383:787–793.
  4. Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani AM, Schwartz LB, Durham SR, Jeffery PK, Kay AB: Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991;88:661–674.
  5. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298–304.
  6. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR: Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993;8:35–42.
  7. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR: Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313–324.
  8. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM: Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996;183:109–117.
  9. Nakajima H, Iwamoto I, Tomoe S, Matsumura R, Tomioka H, Takatsu K, Yoshida S: CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992;146:374–377.
  10. Gavett SH, Chen X, Finkelman F, Wills-Karp M: Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol 1994;10:587–593.
  11. Lukacs NW, Strieter RM, Chensue SW, Kunkel SL: Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma. Am J Respir Cell Mol Biol 1994;10:526–532.
  12. Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cuvelier CA, Pauwels RA, Bluethmann H: Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994;24:73–80.
  13. Kuperman D, Schofield B, Wills-Karp M, Grusby MJ: Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 1998;187:939–948.
  14. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG: Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195–201.
  15. Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE, Brenneisen IE, Horton MA, Haczku A, Gelfand EW, Leikauf GD, Lee NA: Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997;185:2143–2156.
  16. Martin TR, Takeishi T, Katz HR, Austen KF, Drazen JM, Galli SJ: Mast cell activation enhances airway responsiveness to methacholine in the mouse. J Clin Invest 1993;91:1176–1182.
  17. Cieslewicz G, Tomkinson A, Adler A, Duez C, Schwarze J, Takeda K, Larson KA, Lee JJ, Irvin CG, Gelfand EW: The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J Clin Invest 1999;104:301–308.
  18. Coyle AJ, Le Gros G, Bertrand C, Tsuyuki S, Heusser CH, Kopf M, Anderson GP: Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 1995;13:54–59.
  19. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD: Interleukin-13: Central mediator of allergic asthma. Science 1998;282:2258–2261.
  20. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Corry DB: Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998;282:2261–2263.
  21. de Waal Malefyt R, Abrams JS, Zurawski SM, Lecron J-C, Mohan- Peterson S, Sanjanwala B, Bennett BF, Silver J, de Vries JE, Yssel H: Differential regulation of IL-4 and IL-13 expression by human T cell clones and EBV-transformed B cells. Int Immunol 1995;7:1405–1416.
  22. Sornasse T, Larenas P, Davis KA, de Vries JE, Yssel H: Differentiation and stability of Th1 and Th2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med 1996;184:473–483.
  23. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts J, Britten K, Bews JP, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST: Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992;176:1381–1386.
  24. Schmitz J, Thiel A, Kuhn R, Rajewsky K, Müller W, Assenmacher M, Radbruch A: Induction of interleukin 4 (IL-4) expression in T helper (Th) cells is not dependent on IL-4 from non-Th cells. J Exp Med 1994;179:1349–1353.

    External Resources

  25. Pernis A, Gupta S, Gollob KJ, Garfein E, Coffman RL, Schindler C, Rothman P: Lack of interferon γ receptor β chain and the prevention of interferon γ signaling in TH1 cells. Science 1995;269:245–247.

    External Resources

  26. Groux H, Sornasse T, Cottrez F, de Vries JE, Coffman RL, Roncarolo M-G, Yssel H: Induction of human Th1 cell differentiation results in loss of IFN-γ receptor β-chain expression. J Immunol 1997;158:5627–5631.

    External Resources

  27. Hemmi S, Merlin G, Aguet M: Functional characterization of a hybrid human-mouse interferon γ receptor: Evidence for species-specific interaction of the extracellular receptor domain with a putative signal transducer. Proc Natl Acad Sci USA 1992;89:2737–2741.

    External Resources

  28. Soh J, Donnelly RJ, Kotenko S, Mariano TM, Cook JR, Wang N, Emanuel S, Schwartz B, Miki T, Pestka S: Identification and sequence of an accessory factor required for activation of the human interferon γ receptor. Cell 1994;76:793–802.

    External Resources

  29. Bach EA, Szabo SJ, Dighe AS, Ashkenazi A, Aguet M, Murphy KM, Schreiber RD: Ligand-induced autoregulation of IFN-γ receptor β chain expression in T helper cell subsets. Science 1995;270:1215–1218.

    External Resources

  30. Güler ML, Gorham JD, Hsieh CS, Macke AJ, Steen RG, Dietrich WF, Murphy KM: Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 1996;271:984–987.
  31. Szabo SL, Jacobson NG, Dighe AS, Gubler U, Murphy KM: Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 1995;2:665–675.
  32. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinagaglia F: Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997;185:825–831.
  33. Rogge L, Papi A, Presky DH, Biffi M, Minetti LJ, Miotto D, Agostini C, Semenzato G, Fabbri LM, Sinigaglia F: Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol 1999;162:3926–3932.
  34. Yoshimoto T, Okamura H, Tagawa Y-I, Iwakura Y, Nakanishi K: Interleukin 18 together with interleukin 12 inhibits IgE production by induction of IFN-γ production from activated B cells. Proc Natl Acad Sci USA 1997;94:3948–3953.
  35. Xu D, Chan WL, Leung BP, Hunter D, Schulz K, Carter RW, McInnes IB, Robinson JH, Liew FY: Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med 1998;188:1485–1492.
  36. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K: IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-γ production. J Immunol 1998;161:3400–3407.
  37. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis. Science 1996;272:60–66.
  38. Baggiolini M, Dewald B, Moser B: Human chemokines: An update. Annu Rev Immunol 1997;15:675–705.
  39. Sallusto F, Mackay CR, Lanzavecchia A: Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997;277:2005–2007.
  40. Bonecchi R, Bianchi G, Bordignon PP, d’Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129–134.
  41. Zingoni A, Soto H, Hedrick JA, Stoppacciaro A, Storlazzi CT, Sinigaglia F, d’Ambrosio D, O’Garra A, Robinson D, Rocchi M, Santoni A, Zlotnik A, Napolitano M: The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998;161:547–551.
  42. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, Dayer J-M: CCR5 is characteristic of Th1 lymphocytes. Nature 1998;391:344–345.
  43. Jourdan P, Abbal C, Noraz N, Hori T, Uchiyama T, Vendrell JP, Bousquet J, Taylor T, Pène J, Yssel H: Interleukin-4 induces functional cell-surface expression of CXCR4 on human T cells. J Immunol 1998;160:4153–4157.
  44. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875–883.
  45. Abbal C, Jourdan P, Hori T, Bousquet J, Yssel H, Pène J: T cell receptor-mediated activation of allergen-specific CD45RO+ memory T lymphocytes results in downregulation of cell surface CXCR4 expression and a strongly reduced capacity to migrate in response to SDF-1. Int Immunol 1999;11:1451–1462.

    External Resources

  46. Kelso A, Groves P, Troutt AB, Francis K: Evidence for the stochastic acquisition of cytokine profile by CD4+ T cells activated in a T helper type 2-like response in vivo. Eur J Immunol 1995;25:1168–1175.

    External Resources

  47. Xu D, Chan WL, Leung BP, Huang F-P, Wheeler R, Piedrafita D, Robinson JH, Liew FY: Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 1998;187:787–794.
  48. Löhning M, Stroehmann A, Coyle AJ, Grogan JL, Lin S, Gutierrez-Ramos J-S, Levinson D, Radbruch A, Kamradt T: T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 1998;95:6930–6935.
  49. Klemenz R, Hoffmann S, Werenskiold AK: Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. Proc Natl Acad Sci USA 1989;86:5708–5712.

    External Resources

  50. Tominaga S, Jenkins NA, Gilbert DJ, Copeland NG, Tetsuka T: Molecular cloning of the murine ST2 gene. Characterization and chromosomal mapping. Biochim Biophys Acta 1991;1090:1–8.
  51. Tominaga S-I, Yokota T, Yanagisawa K, Tsukamoto T, Takagi T, Tetsuka T: Nucleotide sequence of a complemetary DNA for human ST2. Biochim Biophys Acta 1992;1171:215–218.
  52. Gavett SH, O’Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M: Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:1527–1536.
  53. Coyle AJ, Wagner K, Bertrand C, Tsuyuki S, Bews J, Heusser C: Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a non-anaphylactogenic anti-IgE antibody. J Exp Med 1996;183:1303–1310.
  54. Hansen G, Berry G, DeKruyff RH, Umetsu DT: Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999;103:175–183.
  55. Randolph DA, Carruthers CJ, Szabo SJ, Murphy KM, Chaplin DD: Modulation of airway inflammation by passive transfer of allergen- specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 1999;162:2375–2383.
  56. Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 1993;11:165–190.
  57. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209–1220.
  58. Ohkawara Y, Lim KG, Xing Z, Glibetic M, Nakano K, Dolovich J, Croitoru K, Weller PF, Jordana M: CD40 expression by human peripheral blood eosinophils. J Clin Invest 1996;97:1761–1766.

    External Resources

  59. Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S: Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996;97:1288–1296.
  60. Koning H, Neijens HJ, Baert MR, Oranje AP, Savelkoul HF: T cell subsets and cytokines in allergic and non-allergic children. II. Analysis and IL-5 and IL-10 mRNA expression and protein production. Cytokine 1997;9:427–436.
  61. Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L: Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 1998;158:1958–1962.
  62. Müller U, Akdis CA, Fricker M, Akdis M, Blesken T, Bettens F, Blaser K: Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 1998;101:747–754.
  63. Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K: Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102:98–106.
  64. Pierkes M, Bellinghausen I, Hultsch T, Metz G, Knop J, Saloga J: Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-γ production of T cells. J Allergy Clin Immunol 1999;103:326–332.
  65. Groux H, Bigler M, de Vries JE, Roncarolo MG: Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 1996;184:19–29.
  66. Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY: IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 1998;160:3555–3561.
  67. Groux H, Bigler M, O’Garra A, Rouleau M, Antonenko S, de Vries JE, Roncarolo M-G: A CD4+ T-cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997;389:737–742.
  68. Powrie F: T cells in inflammatory bowel disease: Protective and pathogenic roles. Immunity 1995;3:171–174.
  69. Groux H, Powrie F: Regulatory T cells and inflammatory bowel disease. Immunol Today 1999;20:442–445.

    External Resources

  70. Kuhn R, Lohler J, Rennick D, Rajewski K, Muller W: Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993;75:263–274.
  71. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 1994;265:1237–1240.
  72. Ohno I, Nitta Y, Yamauchi K, Hoshi H, Honma M, Woolley K, O’Byrne P, Tamura G, Jordana M, Shirato K: Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1996;15:404–409.
  73. Vignola AM, Chanez P, Chiappara G, Merendino A, Zinnanti E, Bousquet J, Bellia V, Bonsignore G: Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases. Clin Exp Immunol 1996;106:114–119.
  74. Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, la-Rocca AM, Bellia V, Bonsignore G, Bousquet J: Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997;156:591–599.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50